Literature DB >> 32640244

Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy.

Eija Pirinen, Mari Auranen, Nahid A Khan, Virginia Brilhante, Niina Urho, Alberto Pessia, Antti Hakkarainen, Juho Kuula Ulla Heinonen, Mark S Schmidt, Kimmo Haimilahti, Päivi Piirilä, Nina Lundbom, Marja-Riitta Taskinen, Charles Brenner, Vidya Velagapudi, Kirsi H Pietiläinen, Anu Suomalainen.   

Abstract

Entities:  

Year:  2020        PMID： 32640244     DOI： 10.1016/j.cmet.2020.05.020

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


× No keyword cloud information.
  4 in total

1.  Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.

Authors:  Hong Yao; Minghui Liu; Leibo Wang; Yumeng Zu; Chou Wu; Chenyu Li; Ruoxi Zhang; Haigen Lu; Feifei Li; Shuang Xi; Shuangquan Chen; Xuanyu Gu; Tianya Liu; Jie Cai; Shirong Wang; Maojun Yang; Guo-Gang Xing; Wei Xiong; Lan Hua; Yefeng Tang; Gelin Wang
Journal:  Cell Res       Date:  2022-04-22       Impact factor: 46.297

2.  Current progress in the therapeutic options for mitochondrial disorders.

Authors:  E Koňaříková; A Marković; Z Korandová; J Houštěk; T Mráček
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

Review 3.  Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations.

Authors:  Angelique Cercillieux; Eleonora Ciarlo; Carles Canto
Journal:  Cell Mol Life Sci       Date:  2022-08-02       Impact factor: 9.207

Review 4.  Hypoxia in Aging and Aging-Related Diseases: Mechanism and Therapeutic Strategies.

Authors:  Yaqin Wei; Sergio Giunta; Shijin Xia
Journal:  Int J Mol Sci       Date:  2022-07-25       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.